Glp-1 Licensing Market Research Report

TABLE OF CONTENT

1. Global Glp-1 Licensing Market — Report Overview
1.1. Scope of The Report
1.2. Market Segment Analysis
1.3. Regulatory Scenario by Region/Country
1.4. Strategic Market Investment Scenario
1.5. Market Analysis by Molecule Type (USD Million/Billion)
1.5.1 Global Glp-1 Licensing Market Share by Molecule Type (2026 & 2035)
1.5.2 Semaglutide
1.5.3 Tirzepatide
1.5.4 Liraglutide
1.5.5 Exenatide
1.5.6 Dulaglutide
1.6. Market Analysis by Application (USD Million/Billion)
1.6.1 Global Glp-1 Licensing Market Share by Application (2026 & 2035)
1.6.2 Type 2 Diabetes
1.6.3 Obesity & Weight Management
1.6.4 Cardiovascular Disease
1.6.5 Nash & Metabolic Disorders
1.7. Market Analysis by Licensing Type (USD Million/Billion)
1.7.1 Global Glp-1 Licensing Market Share by Licensing Type (2026 & 2035)
1.7.2 Out-licensing
1.7.3 In-licensing
1.7.4 Co-development Agreements
1.7.5 Royalty-based Licensing
1.8. Market Analysis by End Use (USD Million/Billion)
1.8.1 Global Glp-1 Licensing Market Share by End Use (2026 & 2035)
1.8.2 Pharmaceutical Companies
1.8.3 Biotechnology Companies
1.8.4 Contract Manufacturing Organizations
2. Drivers, Restraints, Challenges and Opportunities of The Glp-1 Licensing Market
2.1. Driver, Restraint, Challenge and Opportunity Analysis
2.2. Market Driver Analysis
2.3. Market Restraint Analysis
2.4. Market Opportunity Analysis
2.5. Market Challenge Analysis
3. Global Growth Trends
3.1. Industry Trends
3.2. SWOT Analysis
3.2.1 Strengths
3.2.2 Weaknesses
3.2.3 Opportunities
3.2.4 Threats
3.3. PESTEL Analysis
3.3.1 Political Landscape
3.3.2 Economic Landscape
3.3.3 Social Landscape
3.3.4 Technological Landscape
3.3.5 Environmental Landscape
3.3.6 Legal Landscape
3.4. Porter's Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitutes
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5. Value Chain Analysis
3.6. Trends by Region
4. Competitive Landscape
4.1. Global Glp-1 Licensing Market, Sales Area, Product Type
4.2. Mergers & Acquisitions, Partnerships, Product Launches and Collaborations in The Global Glp-1 Licensing Market
4.3. Company List in The Global Glp-1 Licensing Market
4.4. Top Companies Market Share (%), 2025
5. Executive Summary
5.1. Global Glp-1 Licensing Market Forecast, 2022–2035 (USD Million/Billion)
5.2. Global Glp-1 Licensing Market Size (USD Million/Billion)
5.3. Global Glp-1 Licensing Market Size and Market Share by Molecule Type (2022–2035) (USD Million/Billion)
5.4. Global Glp-1 Licensing Market Size and Market Share by Molecule Type (2022–2035)
5.5. Global Glp-1 Licensing Market Size and Market Share by Application (2022–2035) (USD Million/Billion)
5.6. Global Glp-1 Licensing Market Size and Market Share by Application (2022–2035)
5.7. Global Glp-1 Licensing Market Size and Market Share by Licensing Type (2022–2035) (USD Million/Billion)
5.8. Global Glp-1 Licensing Market Size and Market Share by Licensing Type (2022–2035)
5.9. Global Glp-1 Licensing Market Size and Market Share by End Use (2022–2035) (USD Million/Billion)
5.10. Global Glp-1 Licensing Market Size and Market Share by End Use (2022–2035)
5.11. Global Glp-1 Licensing Market Size and Market Share by Region (2022–2035) (USD Million/Billion)
5.12. Global Glp-1 Licensing Market Size and Market Share by Region (2022–2035)
5.12.1 North America
5.12.2 Europe
5.12.3 Asia Pacific
5.12.4 Latin America
5.12.5 Middle East & Africa
6. North America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion)
6.1. North America Glp-1 Licensing Market Size by Country (2022–2035)
6.1.1 United States
6.1.2 Canada
6.1.3 Mexico
6.2. North America Glp-1 Licensing Market Size by Molecule Type (2022–2035)
6.3. North America Glp-1 Licensing Market Size by Application (2022–2035)
6.4. North America Glp-1 Licensing Market Size by Licensing Type (2022–2035)
6.5. North America Glp-1 Licensing Market Size by End Use (2022–2035)
7. Europe Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion)
7.1. Europe Glp-1 Licensing Market Size by Country (2022–2035)
7.1.1 United Kingdom
7.1.2 Germany
7.1.3 France
7.1.4 Spain
7.1.5 Italy
7.1.6 Rest of Europe
7.2. Europe Glp-1 Licensing Market Size by Molecule Type (2022–2035)
7.3. Europe Glp-1 Licensing Market Size by Application (2022–2035)
7.4. Europe Glp-1 Licensing Market Size by Licensing Type (2022–2035)
7.5. Europe Glp-1 Licensing Market Size by End Use (2022–2035)
8. Asia Pacific Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion)
8.1. Asia Pacific Glp-1 Licensing Market Size by Country (2022–2035)
8.1.1 China
8.1.2 India
8.1.3 Japan
8.1.4 Australia
8.1.5 South Korea
8.1.6 Rest of Asia Pacific
8.2. Asia Pacific Glp-1 Licensing Market Size by Molecule Type (2022–2035)
8.3. Asia Pacific Glp-1 Licensing Market Size by Application (2022–2035)
8.4. Asia Pacific Glp-1 Licensing Market Size by Licensing Type (2022–2035)
8.5. Asia Pacific Glp-1 Licensing Market Size by End Use (2022–2035)
9. Latin America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion)
9.1. Latin America Glp-1 Licensing Market Size by Country (2022–2035)
9.1.1 Brazil
9.1.2 Argentina
9.1.3 Rest of Latin America
9.2. Latin America Glp-1 Licensing Market Size by Molecule Type (2022–2035)
9.3. Latin America Glp-1 Licensing Market Size by Application (2022–2035)
9.4. Latin America Glp-1 Licensing Market Size by Licensing Type (2022–2035)
9.5. Latin America Glp-1 Licensing Market Size by End Use (2022–2035)
10. Middle East & Africa Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion)
10.1. Middle East & Africa Glp-1 Licensing Market Size by Country (2022–2035)
10.1.1 Saudi Arabia
10.1.2 South Africa
10.1.3 Rest of MEA
10.2. Middle East & Africa Glp-1 Licensing Market Size by Molecule Type (2022–2035)
10.3. Middle East & Africa Glp-1 Licensing Market Size by Application (2022–2035)
10.4. Middle East & Africa Glp-1 Licensing Market Size by Licensing Type (2022–2035)
10.5. Middle East & Africa Glp-1 Licensing Market Size by End Use (2022–2035)
11. Company Profiles
11.1. Novo Nordisk
11.1.1 Company Details
11.1.2 Financials (USD Millions)
11.1.3 Product Summary
11.1.4 Recent Developments
11.2. Eli Lilly And Company
11.3. Pfizer
11.4. Astrazeneca
11.5. Sanofi
11.6. Roche
11.7. Amgen
11.8. Boehringer Ingelheim
11.9. Gsk
11.10. Merck & Co.
11.11. Zealand Pharma
11.12. Hanmi Pharmaceutical
11.13. Innovent Biologics
11.14. Structure Therapeutics
11.15. Viking Therapeutics
11.16. Terns Pharmaceuticals
11.17. Sun Pharmaceutical Industries
11.18. Gan & Lee Pharmaceuticals
11.19. Jiangsu Hengrui Pharmaceuticals
11.20. Kailera Therapeutics
12. Conclusion
13. Reference Link
14. Appendix
14.1. Methodology
14.2. Research Data Source
14.3. Secondary Data
14.3.1 Key Data from Secondary
14.4. Primary Data
14.4.1 Key Data from Primary
14.5. Industry Insight from Professional Leaders
14.6. Market Estimation
14.7. Market Estimation: Top-Down and Bottom-Up Approach
14.8. Legal Disclaimer
15. Insightorax – Market Research & Consulting

LIST OF TABLES

Table 1.1 Market Segment
Table 1.2 Global Glp-1 Licensing Market Growth Rate by Molecule Type (USD Million/Billion) (2026 & 2035)
Table 1.3 Global Glp-1 Licensing Market Growth Rate by Application (USD Million/Billion) (2026 & 2035)
Table 1.4 Global Glp-1 Licensing Market Growth Rate by Licensing Type (USD Million/Billion) (2026 & 2035)
Table 1.5 Global Glp-1 Licensing Market Growth Rate by End Use (USD Million/Billion) (2026 & 2035)
Table 3.1 Trends by Region
Table 4.1 Global Glp-1 Licensing Market, Sales Area, Product Type
Table 4.2 Mergers & Acquisitions, Partnerships, Product Launches and Collaborations in The Global Glp-1 Licensing Market
Table 4.3 Company List in The Global Glp-1 Licensing Market
Table 5.1 Global Glp-1 Licensing Market — Market Snapshot & Key Buying Criteria, 2022–2035
Table 5.2 Global Glp-1 Licensing Market Size (USD Million/Billion) (2022–2035)
Table 5.3 Global Glp-1 Licensing Market Size by Molecule Type (2022–2035)
Table 5.4 Global Glp-1 Licensing Market Share by Molecule Type (2022–2035)
Table 5.5 Global Glp-1 Licensing Market Growth Rate by Molecule Type (2022–2035)
Table 5.6 Global Glp-1 Licensing Market CAGR by Molecule Type (2022–2035)
Table 5.7 Global Glp-1 Licensing Market Size by Application (2022–2035)
Table 5.8 Global Glp-1 Licensing Market Share by Application (2022–2035)
Table 5.9 Global Glp-1 Licensing Market Growth Rate by Application (2022–2035)
Table 5.10 Global Glp-1 Licensing Market CAGR by Application (2022–2035)
Table 5.11 Global Glp-1 Licensing Market Size by Licensing Type (2022–2035)
Table 5.12 Global Glp-1 Licensing Market Share by Licensing Type (2022–2035)
Table 5.13 Global Glp-1 Licensing Market Growth Rate by Licensing Type (2022–2035)
Table 5.14 Global Glp-1 Licensing Market CAGR by Licensing Type (2022–2035)
Table 5.15 Global Glp-1 Licensing Market Size by End Use (2022–2035)
Table 5.16 Global Glp-1 Licensing Market Share by End Use (2022–2035)
Table 5.17 Global Glp-1 Licensing Market Growth Rate by End Use (2022–2035)
Table 5.18 Global Glp-1 Licensing Market CAGR by End Use (2022–2035)
Table 5.19 Global Glp-1 Licensing Market Size by Region (2022–2035)
Table 5.20 Global Glp-1 Licensing Market Share by Region (2022–2035)
Table 5.21 Global Glp-1 Licensing Market Growth Rate by Region (2022–2035)
Table 5.22 Global Glp-1 Licensing Market CAGR by Region (2022–2035)
Table 6.1 North America Glp-1 Licensing Market Size by Country (2022–2035)
Table 6.2 North America Glp-1 Licensing Market Size by Molecule Type (2022–2035)
Table 6.3 North America Glp-1 Licensing Market Size by Application (2022–2035)
Table 6.4 North America Glp-1 Licensing Market Size by Licensing Type (2022–2035)
Table 6.5 North America Glp-1 Licensing Market Size by End Use (2022–2035)
Table 7.1 Europe Glp-1 Licensing Market Size by Country (2022–2035)
Table 7.2 Europe Glp-1 Licensing Market Size by Molecule Type (2022–2035)
Table 7.3 Europe Glp-1 Licensing Market Size by Application (2022–2035)
Table 7.4 Europe Glp-1 Licensing Market Size by Licensing Type (2022–2035)
Table 7.5 Europe Glp-1 Licensing Market Size by End Use (2022–2035)
Table 8.1 Asia Pacific Glp-1 Licensing Market Size by Country (2022–2035)
Table 8.2 Asia Pacific Glp-1 Licensing Market Size by Molecule Type (2022–2035)
Table 8.3 Asia Pacific Glp-1 Licensing Market Size by Application (2022–2035)
Table 8.4 Asia Pacific Glp-1 Licensing Market Size by Licensing Type (2022–2035)
Table 8.5 Asia Pacific Glp-1 Licensing Market Size by End Use (2022–2035)
Table 9.1 Latin America Glp-1 Licensing Market Size by Country (2022–2035)
Table 9.2 Latin America Glp-1 Licensing Market Size by Molecule Type (2022–2035)
Table 9.3 Latin America Glp-1 Licensing Market Size by Application (2022–2035)
Table 9.4 Latin America Glp-1 Licensing Market Size by Licensing Type (2022–2035)
Table 9.5 Latin America Glp-1 Licensing Market Size by End Use (2022–2035)
Table 10.1 Middle East & Africa Glp-1 Licensing Market Size by Country (2022–2035)
Table 10.2 Middle East & Africa Glp-1 Licensing Market Size by Molecule Type (2022–2035)
Table 10.3 Middle East & Africa Glp-1 Licensing Market Size by Application (2022–2035)
Table 10.4 Middle East & Africa Glp-1 Licensing Market Size by Licensing Type (2022–2035)
Table 10.5 Middle East & Africa Glp-1 Licensing Market Size by End Use (2022–2035)

LIST OF FIGURES

Figure 1.1 Market Overview
Figure 2.1 DROC of Glp-1 Licensing Analysis
Figure 3.1 SWOT Analysis
Figure 3.2 PESTEL Analysis
Figure 3.3 Porter's Five Forces Analysis
Figure 5.1 Global Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion)
Figure 5.2 Global Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Molecule Type
Figure 5.3 Global Glp-1 Licensing Market Share (2026 & 2035), by Molecule Type
Figure 5.4 Global Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Application
Figure 5.5 Global Glp-1 Licensing Market Share (2026 & 2035), by Application
Figure 5.6 Global Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Licensing Type
Figure 5.7 Global Glp-1 Licensing Market Share (2026 & 2035), by Licensing Type
Figure 5.8 Global Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by End Use
Figure 5.9 Global Glp-1 Licensing Market Share (2026 & 2035), by End Use
Figure 5.10 Global Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Region
Figure 5.11 Global Glp-1 Licensing Market Share (2026 & 2035), by Region
Figure 6.1 North America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Country
Figure 6.2 North America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Molecule Type
Figure 6.3 North America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Application
Figure 6.4 North America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Licensing Type
Figure 6.5 North America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by End Use
Figure 7.1 Europe Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Country
Figure 7.2 Europe Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Molecule Type
Figure 7.3 Europe Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Application
Figure 7.4 Europe Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Licensing Type
Figure 7.5 Europe Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by End Use
Figure 8.1 Asia Pacific Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Country
Figure 8.2 Asia Pacific Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Molecule Type
Figure 8.3 Asia Pacific Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Application
Figure 8.4 Asia Pacific Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Licensing Type
Figure 8.5 Asia Pacific Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by End Use
Figure 9.1 Latin America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Country
Figure 9.2 Latin America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Molecule Type
Figure 9.3 Latin America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Application
Figure 9.4 Latin America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Licensing Type
Figure 9.5 Latin America Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by End Use
Figure 10.1 Middle East & Africa Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Country
Figure 10.2 Middle East & Africa Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Molecule Type
Figure 10.3 Middle East & Africa Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Application
Figure 10.4 Middle East & Africa Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by Licensing Type
Figure 10.5 Middle East & Africa Glp-1 Licensing Market Size (2022–2035) (USD Million/Billion), by End Use